The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials
article has not abstract
Vyšlo v časopise:
The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials. PLoS Med 9(11): e32767. doi:10.1371/journal.pmed.1001346
Kategorie:
Guidelines and Guidance
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001346
Souhrn
article has not abstract
Zdroje
1. Donner A, Klar N (2000) Design and analysis of cluster randomization trials in health research. London: Arnold. 178 p.
2. Hayes RJ, Moulton LH (2009) Cluster randomised trials. Boca Raton (Florida): Chapman & Hall/CRC. 315 p.
3. Eldridge S, Kerry S (2012) A practical guide to cluster randomised trials in health services research. Chichester (United Kingdom): John Wiley & Sons. 278 p.
4. Boruch RF (2005) Place randomized trials: experimental tests of public policy. Thousand Oaks (California): Sage Publications. 292 p.
5. Murray DM (1998) Design and analysis of group-randomized trials. New York: Oxford University Press. 467 p.
6. CampbellMK, PiaggioG, ElbourneDR, AltmanDG (2012) for the CONSORT Group (2012) CONSORT 2010 statement: extension to cluster randomised trials. BMJ 345: e5661.
7. IsaakidisP, IoannidisJP (2003) Evaluation of cluster randomized controlled trials in sub-Saharan Africa. Am J Epidemiol 158: 921–926.
8. EdwardsSJL, BraunholtzDA, LilfordRJ, StevensAJ (1999) Ethical issues in the design and conduct of cluster randomised controlled trials. BMJ 318: 1407–1409.
9. HuttonJL (2001) Are distinctive ethical principles required for cluster randomized controlled trials? Stat Med 20: 473–488.
10. EldridgeSM, AshbyD, FederGS (2005) Informed patient consent to participation in cluster randomized trials: an empirical exploration of trials in primary care. Clin Trials 2: 91–98.
11. Klar N, Donner A (2007) Ethical challenges posed by cluster randomization. In: D'Agostino EB, Sullivan LM, Massaro J, editors. Wiley encyclopedia of clinical trials. Hoboken (New Jersey): John Wiley & Sons. doi:10.1002/9780471462422.eoct050
12. MannH, ReyesM (2008) Identifying the human research subject in cluster randomized controlled trials. IRB 30: 14–18.
13. SimJ, DawsonA (2012) Informed consent and cluster-randomized trials. Am J Public Health 102: 480–485.
14. TaljaardM, WeijerC, GrimshawJ, Belle BrownJ, BinikA, et al. (2009) Study protocol: ethical and policy issues in cluster randomized trials: rationale and design of a mixed methods research study. Trials 10: 61.
15. TaljaardM, McRaeA, WeijerC, BennettC, DixonS, et al. (2011) Inadequate reporting of research ethics review and informed consent in cluster randomized trials: review of a representative sample of published trials. BMJ 342: d2496.
16. WeijerC, GrimshawJM, TaljaardM, BinikA, BoruchR, et al. (2011) Ethical issues posed by cluster randomized trials in health research. Trials 12: 100.
17. BinikA, WeijerC, McRaeAD, GrimshawJM, BoruchR, et al. (2011) Does clinical equipoise apply to cluster randomized trials in health research? Trials 12: 118.
18. McRaeAD, WeijerC, BinikA, WhiteA, GrimshawJM, et al. (2011) Who is the research subject in cluster randomized trials? Trials 12: 183.
19. McRaeAD, WeijerC, BinikA, GrimshawJM, BoruchR, et al. (2011) When is informed consent required in cluster randomized trials in health research? Trials 12: 202.
20. GalloA, WeijerC, WhiteA, GrimshawJM, BoruchR, et al. (2012) What is the role and authority of gatekeepers in cluster randomized trials in health research? Trials 13: 116.
21. PufferS, TorgersonD, WatsonJ (2003) Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. BMJ 327: 785–789.
22. HayesRJ, BennettS (1999) Simple sample size calculation for cluster-randomized trials. Int J Epidemiol 28: 319–326.
23. KerrySM, BlandJM (1998) Trials which randomize practices I: how should they be analysed? Fam Pract 15: 80–83.
24. KerrySM, BlandJM (1998) Trials which randomize practices II: sample size. Fam Pract 15: 84–87.
25. CampbellMK, MollisonJ, SteenN, GrimshawJM, EcclesM (2000) Analysis of cluster randomized trials in primary care: a practical approach. Fam Pract 17: 192–196.
26. DonnerA, KlarN (1996) Statistical considerations in the design and analysis of community intervention trials. J Clin Epidemiol 49: 435–439.
27. DonnerA, KlarN (1994) Methods for comparing event rates in intervention studies when the unit of allocation is a cluster. Am J Epidemiol 140: 279–289.
28. TorgersonDJ (2001) Contamination in trials: is cluster randomisation the answer? BMJ 322: 355–357.
29. EldridgeS, KerryS, TorgersonDJ (2009) Bias in identifying and recruiting participants in cluster randomised trials: what can be done? BMJ 339: b4006.
30. HahnS, PufferS, TorgersonDJ, WatsonJ (2005) Methodological bias in cluster randomised trials. BMC Med Res Methodol 5: 10.
31. KopelmanLM (2004) Minimal risk as an international ethical standard in research. J Med Philos 29: 351–378.
32. Ross LF (2008) Children in medical research: access versus protection. New York: Oxford University Press. 304 p.
33. SmeltAF, van der WeeleGM, BlomJW, GusseklooJ, AssendelftWJ (2010) How usual is usual care in pragmatic intervention studies in primary care? An overview of recent trials. Br J Gen Pract 60: e305–e318.
34. EcclesM, GrimshawJ, SteenN, ParkinD, PurvesI, et al. (2000) The design and analysis of a randomized controlled trial to evaluate computerized decision support in primary care: the COGENT study. Fam Pract 17: 180–186.
35. GrimshawJ, CampbellM, EcclesM, SteenN (2000) Experimental and quasi-experimental designs for evaluating guideline implementation strategies. Fam Pract 17: S11–S18.
36. IvesJ, DraperH, DameryS, WilsonS (2009) Do family doctors have an obligation to facilitate research? Fam Pract 26: 543–548.
37. WeijerC, MillerPB (2004) When are research risks reasonable in relation to anticipated benefits? Nat Med 10: 570–573.
38. ZwarensteinM, TreweekS (2009) What kind of randomized trials do we need? CMAJ 180: 998–1000.
39. ConradE, EdwardsSJL (2011) Inequalities and fairness in cluster trials. Res Ethics 7: 58–65.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2012 Číslo 11
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Pleiotropní účinky statinů na kardiovaskulární systém
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
- Význam hydratace při hojení ran
Najčítanejšie v tomto čísle
- G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map
- Screening for Chronic Kidney Disease: Preventing Harm or Harming the Healthy?
- The Long-Term Health Consequences of Child Physical Abuse, Emotional Abuse, and Neglect: A Systematic Review and Meta-Analysis
- Screening and Rapid Molecular Diagnosis of Tuberculosis in Prisons in Russia and Eastern Europe: A Cost-Effectiveness Analysis